# INFLECTRA

NDC: 0069-0809
Generic name: infliximab-dyyb
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20161121

FDA application: BLA125544

## Active ingredients

- INFLIXIMAB: 100 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-0809"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0809
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=37eaca10-d812-48bc-8b8e-b836bfa9968f